Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA places partial clinical hold on Magrolimab studies in acute myeloid leukemia: Gilead Sciences

Ruchika Sharma22 Aug 2023 12:30 PM IST

Magrolimab is a potential first-in-class investigational anti-CD47 immunotherapy.

Pfizer discontinues development of danuglipron for chronic weight management

Pfizer maternal vaccine Abrysvo bags USFDA approval for RSV prevention in infants

Ruchika Sharma22 Aug 2023 11:26 AM IST

New York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO (Respiratory Syncytial Virus Vaccine),...

Aurobindo Pharma, Alembic Pharma recall drugs in US over manufacturing lapses

Ruchika Sharma21 Aug 2023 4:58 PM IST

New Delhi: Alembic Pharmaceuticals and Aurobindo Pharma are recalling different products in the US market due to manufacturing lapses, according to...

No concerns about Medtronic, Otsuka BP devices raised by USFDA staff

Ruchika Sharma21 Aug 2023 2:30 PM IST

The staff reviewers said the available safety data for the device made by ReCor, a unit of Otsuka Holdings, did not raise concerns, while pointing...

Regeneron Pharma Eylea HD injection approved by USFDA for treatment of Wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy

Ruchika Sharma21 Aug 2023 1:30 PM IST

Tarrytown: Regeneron Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA HD...

NIPERs to become world class research institutes by establishing Centres of Excellence, creating a talent pool of qualified and trained students

Ruchika Sharma21 Aug 2023 12:40 PM IST

New Delhi: Union Minister of Health and Family Welfare and Chemicals and Fertilizers, Dr Mansukh Mandaviya accompanied the G-20 Ministers and...

Medicines manufactured in India saves lives in Netherlands, Europe, across world: Netherlands Health Minister

Ruchika Sharma21 Aug 2023 11:30 AM IST

Dr Mandaviya leads G20 delegation on a visit to Jan Aushadhi Kendras.

AbbVie gets European Commission nod for Aquipta for prophylaxis of migraine in adults

Ruchika Sharma20 Aug 2023 3:00 PM IST

North Chicago: AbbVie has announced that the European Commission has approved AQUIPTA (atogepant) for the prophylaxis of migraine in adults...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca Forxiga approved in China to reduce cardiovascular death, hospitalisation risk in adults with symptomatic chronic heart failure

Ruchika Sharma20 Aug 2023 1:30 PM IST

Forxiga is a first-in-class, oral, once-daily selective inhibitor of human sodium-glucose co-transporter 2 (SGLT2).

Janssen-Cilag Guselkumab receives UK nod for Crohns disease, ulcerative colitis

European Commission nod to reduced dosing frequency for Janssen Tecvayli

Ruchika Sharma20 Aug 2023 11:30 AM IST

Teclistamab is an off-the-shelf (or ready to use) bispecific antibody.

Boehringer Ingelheim Jascayd receives regulatory approval for progressive pulmonary fibrosis in China

Boehringer Ingelheim to advance Survodutide into 3 global Phase III studies in obesity

Ruchika Sharma20 Aug 2023 10:00 AM IST

Germany: Boehringer Ingelheim has announced it will advance survodutide, its glucagon/GLP-1 receptor dual agonist, into three registrational Phase III...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck declares topline results from Phase 3 trial of Welirag

Ruchika Sharma19 Aug 2023 4:04 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced topline results from LITESPARK-005, the first positive Phase 3...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok